CMA Board MembersBoard Forum Page (Login Required)
The CMA Board comprises a blend of experience, skills and vision necessary to ensure the success of the complementary healthcare industry.
Annual Directors Report 2022
We are pleased to present CMA’s Director’s Report for 2022. It highlights the organisation's achievements and activities across the key areas outlined in the organisation's Strategic Plan: Healthy People, Healthy Future 2020-2025, with a fresh approach that will Protect, Campaign for and Grow our industry.
Ben Rowe - Brauer Natural Medicine - Chief Executive Officer
Ben has over 25 years of experience in business development, marketing, strategy and general management roles across a variety of industries.
He holds a Bachelor of Economics, Associate Diploma in Marketing and in 2016 was awarded an Industry Leaders Fund scholarship to study the Advanced Management Program at INSEAD Business School.
Ben Rowe has been the CEO of Brauer Natural Medicine for the past 6 years and became a Board Member of Complementary Medicines Australia in 2015.
CMA Vice President
Paula Hann has worked for Metagenics ANZ for over 17 years. During this time she has worked in various roles in sales and marketing on both the Practitioner and retail side of the business. In her time at Metagenics ANZ Paula has been responsible for multimillion dollar marketing budgets, and played an integral role in the marketing and promotion of leading retail brands like Inner Health and Ethical Nutrients.
Paula and her team have lead the delivery to market of industry first probiotics and novel delivery systems of natural medicines. Paula has also played a key role in driving the growth of market leading Practitioner brand, Metagenics, and is proud of the industry leading education for healthcare professional that Metagenics provides. She is a passionate advocate for the industry and believes that natural medicine is the medicine of the future, and it’s role will only become more important as we battle to address the rising tide of chronic disease.
John Bylicki - CEO Proprietor at Go Vita Stanthorpe, Go Vita Warwick
John is an experienced board director at a National level. John is past President of the local Chamber of Commerce and experienced small business owner since 2000 and involved with a number of Community groups. John is passionate about the power of community and the potential of social wellness.
Carl Gibson - Complementary Medicines Australia, Chief Executive Officer
Zephanie Jordan, Chief R&D and Quality Officer at Pharmacare Laboratories
Zephanie has worked in the Consumer Healthcare industry for more than 25 years in Australia and overseas. She has experience leading and balancing regulatory compliance, innovation and policy influence in healthcare, food, cosmetic and chemical companies.
She has worked for RB, J&J, GSK, Boots Healthcare, Faulding and P&G. She has also worked for ASMI (now CHPA) as Scientific Director and it was during this time that she collaborated with the former Complementary Healthcare Council (CHC) on a range of issues. In 2004-5 she was an independent consultant and was contracted by the TGA to work on the Complementary Medicines Evidence Guidelines. Zephanie holds qualifications in Food Science, Pharmaceutical Science and Wine Science. She is an advocate for self-care, championing policy reform to drive proportionate regulation and incentives for innovation.
Eric Chen - Chief Executive Officer, Life-Space Group, CA, CICPA, AICPA
Eric is the CEO of Life-Space Group, a leading Australian company specialising in probiotics and microbiome with fast growing distribution networks across ANZ, China, SEA and North America, via the strong supports from its parent entity: By-Health (the No.1 VMS brand in China).
Eric is equipped with solid knowledge and skills in corporate strategy formation & execution, business operation management, talent mentoring & development through leveraging his experience in large multinational corporate environment over 17 years.
Eric also has proved leadership and capabilities in diversified & cross-country business environment to bridge the gap between eastern and western culture. He holds an MBA degree from the University of Liverpool in U.K.
Eric is passionate about the power of microbiome and the important role probiotics play in both human and planetary health. Leveraging his strong industrial insights & international vision and experience, he is keen to contribute his own and his organisation’s efforts to help CMA uplift the awareness & influence of the whole industry and also continue to bring premium and innovative health solutions to consumers.
John O’Doherty, Head of Public Affairs, Blackmores Group
Prior to joining Blackmores in 2018, John worked for the Australian Government in a Senior Adviser capacity for the Health, Industry Innovation Science and Environment portfolios. John has also worked for financial consulting and law firms, and has covered federal politics as a member of the Press Gallery in Canberra.
Gulhan Demirci - Innovation and NPD Manager at NutriSmart Australia
Senior Manager in the areas of Product Development, Compliance and Regulations. With over 22 years of industry experience in a variety of R&D and commercialization areas mainly focused on Pharmaceuticals and Complementary Medicines.
Dr Michael Osiecki, PhD, BBE (Chemical), BBiotech (Hons)
Dr Michael is the Managing Director of Bio Concepts and the second generation of Osiecki biochemists. With scientific prowess and a passion for the industry, Dr Michael is at the forefront of education in nutritional medicine.
Nick Mann- CEO ANZ & Asia, Swisse Wellness(H&H Group)
Nick is the CEO for Australia, New Zealand and Asia for the Health & Happiness Group, a global company who owns brands including Swisse Wellness and Biostime. Nick has held senior leadership roles in sales, marketing and general management across South East Asia for almost 30 years.
Nick joined Swisse as Director of Sales for ANZ and reenergized the sales team, bringing a new sense of purpose and vibrancy. Nick was promoted to the role of Managing Director, ANZ in September 2019 and to CEO of ANZ and Asia in March 2022.
Peter is an experienced executive who has held roles as: Chief Executive Officer, General Manager, Sales and Marketing Director and Chief Financial Officer (ASX Listed Company),with 20+ years’ experience in senior executive roles within the Vitamins and Dietary Supplements / Healthy Foods industries. Peter is currently the Managing Director / CEO of Designs For Health Australia and is thoroughly enjoying the challenge of a "start up".
Rachel Carter - Head of Sales and Marketing, SFI Health
Rachel has over 25 years’ experience in Sales and Marketing with a passion for natural health and leadership. In 2016 Rachel merged her passions and entered the world of contract manufacturing heading up the Nutraceuticals division for Australian Pharmaceutical Manufacturing where her team managed and serviced Swisse and Blackmores before joining Frank Caruso at Carusos Natural Health on his Leadership Team in 2018.
Rachel first started her career, after studying Sales and Marketing, in retail where she was the youngest manager within the Organisation at the age of 19. She then went onto follow her business to business ambitions in FMCG where she enjoyed 10 wonderful years moving through the ranks from Sales Representative through to Marketing Manager, before becoming a mother to 2 beautiful girls.
Her strength in leadership combined with her sales, marketing
negotiation and strategy skills is what drives her every day to make a
difference in her people, herself and the industry she represents.
Andrew O’Keefe - Vita Life Sciences Managing Director
Andrew has over 20 years’ experience within the complementary medicine and pharmaceutical industries. Andrew is currently the Managing Director for Vita Life Sciences, a listed company on the Australian stock exchange. Vita Life Sciences is a multinational healthcare company that formulates and distributes a range of vitamins and supplements, including Herbs of Gold and VitaHealth brands, across Australia and South East Asia.